183588-68-3Relevant academic research and scientific papers
INHIBITORS OF PHOSPHODIESTERASE TYPE-IV
-
Page/Page column 6, (2009/09/08)
The present invention relates to oxazine derivatives, which can be used as selective inhibitors of phosphodiesterase (PDE) type IV. Compounds disclosed herein can be useful in the treatment of CMS disorders, AIDS, asthma, arthritis, bronchitis, chronic ob
INHIBITORS OF PHOSPHODIESTERASE TYPE-IV
-
Page/Page column 15, (2008/06/13)
The present invention relates to oxazine derivatives, which can be used as selective inhibitors of phosphodiesterase (PDE) type IV. Compounds disclosed herein can be useful in the treatment of CMS disorders, AIDS, asthma, arthritis, bronchitis, chronic ob
1,3-DIHYDRO-2H-IMIDAZOLE-2-ONE COMPOUNDS
-
, (2008/06/13)
The present invention concerns the compounds of formula (I) the N-oxide forms, the pharmaceutically acceptable acid or base addition salts and the stereochemically isomeric forms thereof, wherein R1 and R2 each independently are hydrogen; C1-6alkyl; diflu
1,3-dihydro-1-(phenylalkyl)-2H-imidazol-2-one compounds and their use for treating allergic, atopic or inflammatory diseases
-
, (2008/06/13)
The present invention describes 1,3-dihydro-1-(phenylalkyl)-2H-imidazol-2-one compounds and their use for treating warm-blooded animals suffering from disease states related to an abnormal enzymatic or catalytic activity of phosphodiesterase IV (PDE IV),
1,3-DIHYDRO-1-(PHENYLALKENYL)-2H-IMIDAZOL-2-ONE DERIVATIVES HAVING PDE IV AND CYTOKINE INHIBITING ACTIVITY
-
, (2008/06/13)
The present invention concerns the compounds of formula STR1 the N-oxide forms, the pharmaceutically acceptable acid or base addition salts and the stereochemically isomeric forms thereof, wherein R. sup.1 and R. sup. 2 each independently are hydrogen; C
